Biodistribution and elimination study of fluorine-18 labeled Nε-carboxymethyl-lysine following intragastric and intravenous administration

PloS One
Hongzeng XuNaifeng Liu


N(ε)-carboxymethyl-lysine (CML) is a major advanced glycation end-product (AGEs) widely found in foods. The aim of our study was to evaluate how exogenous CML-peptide is dynamically absorbed from the gastrointestinal tract and eliminated by renal tubular secretion using microPET imaging. The present study consisted of three investigations. In study I, we synthesized the imaging tracer (18)F-CML by reacting N-succinimidyl 4-(18)F-fluorobenzoate ((18)F-SFB) with CML. In study II, the biological activity of (18)F-CML was evaluated in RAW264.7 cells and HepG2 cells. In study III, the biodistribution and elimination of AGEs in ICR mice were studied in vivo following tail vein injection and intragastric administration of (18)F-CML. The formation of (18)F-CML was confirmed by comparing its retention time with the corresponding reference compound (19)F-CML. The radiochemical purity (RCP) of (18)F-CML was >95%, and it showed a stable character in vitro and in vivo. Uptake of (18)F-CML by RAW264.7 cells and HepG2 cells could be inhibited by unmodified CML. (18)F-CML was quickly distributed via the blood, and it was rapidly excreted through the kidneys 20 min after tail vein injection. However, (18)F-CML was only slightly absorbed followi...Continue Reading


Feb 1, 1987·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·T DelahuntyD Hollander
Jun 10, 1997·Proceedings of the National Academy of Sciences of the United States of America·T KoschinskyH Vlassara
Jul 12, 2002·Diabetes/metabolism Research and Reviews·Feng ZhengHelen Vlassara
Sep 21, 2002·Trends in Cardiovascular Medicine·Akira MiyazakiSeikoh Horiuchi
Apr 16, 2003·Kidney International. Supplement·Thomas Henle
Dec 8, 2004·Journal of Hepatology·Dmitri Svistounov, Bård Smedsrød
Jul 23, 2005·Annals of the New York Academy of Sciences·Anke FörsterThomas Henle
Jul 23, 2005·Annals of the New York Academy of Sciences·Akihiko SaitoFumitake Gejyo
Oct 19, 2006·Nuclear Medicine and Biology·Christina HultschThomas Henle
Apr 25, 2007·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Jaime UribarriHelen Vlassara
May 10, 2007·Nature Protocols·Ganesan Vaidyanathan, Michael R Zalutsky
Sep 15, 2007·Molecular Nutrition & Food Research·Jennifer M Ames
May 2, 2008·Annals of the New York Academy of Sciences·Jennifer M Ames
Mar 26, 2009·Methods : a Companion to Methods in Enzymology·Kim SerdonsGuy M Bormans
Jun 27, 2009·Journal of Agricultural and Food Chemistry·Michael HellwigThomas Henle
Jun 30, 2009·The Journal of Allergy and Clinical Immunology·Katherine R Groschwitz, Simon P Hogan
Oct 27, 2009·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Richard D SembaLuigi Ferrucci
Sep 22, 2010·Advanced Drug Delivery Reviews·Zibo Li, Peter S Conti
Oct 16, 2010·Amino Acids·Frédéric J Tessier, Inès Birlouez-Aragon
Jan 5, 2011·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Marta PiroddiFrancesco Galli
Oct 25, 2011·Trends in Biochemical Sciences·Günter Fritz

❮ Previous
Next ❯


Dec 15, 2015·Journal of Agricultural and Food Chemistry·Mei LiJie Chen
Jun 14, 2017·Chemical Society Reviews·Dion van der BornDanielle J Vugts
Jan 27, 2016·Journal of Animal Science·C van RooijenW H Hendriks
Sep 30, 2020·Glycoconjugate Journal·Frederic J TessierMichael Howsam

❮ Previous
Next ❯

Methods Mentioned

reversed-phase chromatography

Software Mentioned


Related Concepts

Related Feeds

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.